The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women
- PMID: 21173718
- DOI: 10.1097/gme.0b013e318203a46b
The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women
Comment in
-
Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes.Menopause. 2011 Jan;18(1):17-22. doi: 10.1097/gme.0b013e3181e84bb4. Menopause. 2011. PMID: 20689465 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
